BridgeMD
Tests treatment safety and results for CRPS (Complex Regional Pain Syndromes)
Official title The Effectiveness of Conservative Treatment in Patients With Complex Regional Pain Syndrome.
ClinicalTrials.gov ID: NCT07208825
What this study is testing
What is Optimizing the medication?
Optimizing the medication is an investigational medicine, given as an once-daily treatment applied to the skin, being studied as a potential treatment for crps (complex regional pain syndromes).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The aim of the study is to investigate and improve non-pharmacological rehabilitation methods for patients with Complex Regional Pain Syndrome (CRPS) to reduce pain and restore work and functional capacity to lower overall treatment costs. Current treatment methods offer limited rehabilitation potential for this challenging pain condition, so efforts should be made to raise the level of care and rehabilitation for a disease that often causes long-term and severe reductions in patients' functional and occupational abilities.
- Time commitment: about 5 years
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- CRPS symptoms maximum of 5 year at the time of diagnosis (CRPS 1 and 2)
- 18 to 70-year-old
- rTMS treatment is granted by university hospital pain clinic (by multidisciplinary group)
- Voluntary to participate into the study
You likely can't join if
- CRPS symptoms started over five years ago (although diagnosed first time now)
- No other outpatient/inpatient rehabilitation during the study rehabilitation period (insurance company or other third party)
- Under 18-years-old of over 70-years-old
- No eligible to rTMS treatment or for other reason rTMS treatment was not granted by university hospital pain clinic (by multidisciplinary group)
The study team makes the final eligibility decision.
Where it's taking place
- Oulu, North Ostrobothnia, Finland
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 5 years per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Oulu, North Ostrobothnia, Finland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.